Hyperfine (HYPR) Shares Outstanding (Weighted Average) (2020 - 2026)
Hyperfine posted quarterly Shares Outstanding (Weighted Average) of $97.7 million for Q1 2026, up 29.06% year-on-year from $75.7 million in Q1 2025, and up 19.44% on a QoQ basis from $81.8 million in Q4 2025.
Hyperfine (HYPR) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $97.7 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 29.06% year-over-year to $97.7 million; the trailing twelve-month figure through Mar 2026 stood at $97.7 million (up 29.06% YoY), and the FY2025 full-year result was $81.8 million, up 12.96% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $97.7 million, up from $81.8 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $97.7 million in Q1 2026 and bottomed at $70.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $71.9 million (2024), against an average of $74.4 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) jumped 4288.28%; it then increased 0.76% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $70.4 million in 2022, then grew by 1.23% to $71.3 million in 2023, then gained by 1.54% to $72.4 million in 2024, then climbed by 12.96% to $81.8 million in 2025, then increased by 19.44% to $97.7 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $97.7 million (Q1 2026), $81.8 million (Q4 2025), and $77.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 97.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.70 Mn |
| Dec 31, 2025 | 81.80 Mn |
| Sep 30, 2025 | 77.61 Mn |
| Jun 30, 2025 | 76.89 Mn |
| Mar 31, 2025 | 75.70 Mn |
| Dec 31, 2024 | 72.41 Mn |
| Sep 30, 2024 | 72.68 Mn |
| Jun 30, 2024 | 72.04 Mn |
| Mar 31, 2024 | 71.93 Mn |
| Dec 31, 2023 | 71.32 Mn |
| Sep 30, 2023 | 71.18 Mn |
| Jun 30, 2023 | 71.03 Mn |
| Mar 31, 2023 | 70.86 Mn |
| Dec 31, 2022 | 70.45 Mn |
| Sep 30, 2022 | 70.40 Mn |
| Jun 30, 2022 | 70.35 Mn |
| Mar 31, 2022 | 70.33 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 1.89 Mn |
| Jun 30, 2021 | 1.63 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | 1.52 Mn |